Alvotech (ALVO) Research & Development (2021 - 2026)
Alvotech's (ALVO) quarterly Research & Development came in at -$24.5 million in Q1 2026, up 35.78% YoY from -$18.1 million in Q1 2025, and down 107.46% on a QoQ basis from $328.7 million in Q4 2025.
Alvotech (ALVO) Research & Development (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Research & Development data on file, last reported at -$24.5 million in Q1 2026.
- Quarterly Research & Development rose 35.78% year-over-year to -$24.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $197.9 million (up 158.11% YoY) and the FY2025 annual result came in at $184.2 million, up 7.52% from the prior year.
- Research & Development eased to -$24.5 million in Q1 2026, from $328.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $328.7 million in Q4 2025 to a low of -$210.8 million in Q4 2023.
- A 5-year average of -$53.4 million and a median of -$51.6 million in 2025 frame the typical range for Research & Development.
- The widest YoY moves for Research & Development: up 291.87% in 2025, down 76442.07% in 2025.
- Tracing ALVO's Research & Development over 5 years: stood at -$180.6 million in 2022, then declined by 16.72% to -$210.8 million in 2023, then increased by 18.74% to -$171.3 million in 2024, then jumped by 291.87% to $328.7 million in 2025, then tumbled by 107.46% to -$24.5 million in 2026.
- The last three Research & Development figures came in at -$24.5 million (Q1 2026), $328.7 million (Q4 2025), and -$51.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alvotech | 1.23 Bn | 1.23 Bn | 5.09 Mn | -24.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.51 Mn |
| Dec 31, 2025 | 328.70 Mn |
| Sep 30, 2025 | -51.62 Mn |
| Jun 30, 2025 | -54.72 Mn |
| Mar 31, 2025 | -38.17 Mn |
| Dec 31, 2024 | -171.31 Mn |
| Sep 30, 2024 | -33.57 Mn |
| Jun 30, 2024 | -97.43 Mn |
| Mar 31, 2024 | -49,868.00 |
| Dec 31, 2023 | -210.83 Mn |
| Aug 31, 2023 | -99.58 Mn |
| Jun 30, 2023 | -99.53 Mn |
| Mar 31, 2023 | -50,864.00 |
| Dec 31, 2022 | -180.62 Mn |
| Aug 31, 2022 | -86.88 Mn |
| Jun 30, 2022 | -39.75 Mn |
| Mar 31, 2022 | -47.14 Mn |
| Dec 31, 2021 | 337.61 Mn |
| Sep 30, 2021 | -56.20 Mn |